Allied Patients

Allied Patients, Inc. was a pharmaceutical startup founded in 2018 by Dr. Eduardo Matto with the mission of developing and manufacturing affordable generic alternatives for patent-expired branded medications. The company specifically targeted "low-volume, high-need" drugs that were often neglected by larger generic manufacturers due to limited profit potential, which frequently led to monopolies and significant price increases. Allied Patients aimed to utilize a distributed U.S.-based development and manufacturing network to streamline production and ensure FDA compliance. The company sought to revolutionize the pharmaceutical industry by prioritizing patient access over traditional investor-focused volume models. However, the company appears to be currently inactive as the founder has transitioned to a career in academic medicine.